ArticleCureus2026
Association Between Diabetes Mellitus and CT-Measured Optic Nerve Sheath Diameter: A Retrospective Observational Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDiabetes mellitus is associated with microvascular, neurological, and ocular complications. The optic nerve sheath contains a cerebrospinal-fluid-containing subarachnoid space and can be assessed quantitatively on imaging. However, evidence regarding differences in CT-measured optic nerve sheath diameter (ONSD) between diabetic and non-diabetic patients remains limited.
objectiveTo evaluate the association between diabetes mellitus and ONSD measured by CT and determine whether significant differences exist between diabetic and non-diabetic individuals.
methodsThis retrospective observational study included 104 patients aged 18-85 years who underwent non-contrast brain CT between June 2022 and June 2023. The sample comprised 52 diabetic and 52 non-diabetic patients. ONSD was measured bilaterally at 3 mm and 8 mm posterior to the globe using electronic calipers on the Syngo.via workstation. Patients with intracranial, orbital, or optic nerve conditions likely to affect ONSD were excluded. Group differences were evaluated using independent-samples t-tests. Multivariable linear regression models were additionally used to assess the association between diabetes status and ONSD after adjustment for age and sex.
resultsMean age was 56.50 ± 13.08 years in the diabetic group and 45.94 ± 16.57 years in the non-diabetic group. Mean ONSD was greater in diabetic patients at all four sites: right 3 mm, 6.09 ± 0.59 versus 4.39 ± 0.53 mm; left 3 mm, 5.93 ± 0.65 versus 4.52 ± 0.62 mm; right 8 mm, 4.86 ± 0.57 versus 3.73 ± 0.48 mm; and left 8 mm, 4.89 ± 0.59 versus 3.78 ± 0.49 mm. All unadjusted comparisons were statistically significant (t = 15.46, 11.32, 10.93, and 10.44, respectively; all p < 0.001). After adjustment for age and sex, diabetes remained significantly associated with greater ONSD at all four sites.
conclusionDiabetic patients had larger CT-measured ONSD than non-diabetic patients at both 3 mm and 8 mm posterior to the globe. The association remained significant after adjustment for age and sex. These findings support an association between diabetes mellitus and increased ONSD measurements but do not establish causality or a diagnostic cutoff. Prospective studies with standardized measurements and detailed clinical characterization are warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.